Teva Pharmaceutical Industries | TEVA - Sales Revenues

Stock Price
10,090.00
Daily Change
-220.00 -2.13%
Monthly
6.78%
Yearly
66.67%
Q2 Forecast
9,793.35

Teva Pharmaceutical Industries reported $11.77B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Aspen Pharmacare ZAR 17.08B 4.32B Dec/2025
Cipla INR 65.41B 9.77B Mar/2026
Dr.Reddys Laboratories INR 75.46B 11.81B Mar/2026
Guangzhou Baiy CNY 16.05B 7.23B Dec/2026
Jiangsu Hengrui CNY 8.14B 300M Mar/2026
Kalbe Farma IDR 9.34T 431B Mar/2026
Richter Gedeon HUF 214.69B 26.79B Sep/2025
Sh Fosun Pharma CNY 10.07B 260M Dec/2026
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
Teva Pharmaceutical Industries USD 11.77B 2.86B Mar/2026